Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 added and Revision: v3.2.0 removed; this metadata update does not affect study content, including criteria, interventions, or outcomes; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedThe updates appear to be minor formatting adjustments with no changes to essential study details or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check72 days agoChange Detected- Removed reference to Adrenal cortex carcinoma and version v3.1.0. - Added notice about funding lapse and current NIH Clinical Center status, a new term Adenoid cystic carcinoma, and a new revision version v3.2.0.SummaryDifference3%

- Check79 days agoChange DetectedUpdate: version tag upgraded from v3.0.2 to v3.1.0, replacing the old revision with a new one. No other content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' link/text was removed.SummaryDifference0.2%

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.